Combined synopsis and solicitation
Human Donor Blood for Bioassay Development
75F40124Q00461
Food and Drug Administration, FDA Office of Acq Grant SVCS. Blood and Organ Banks.
Awarded
$47,440.00 obligated so far on USAspending
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one was awarded in 2024
1 like it is open now in blood and organ banks
- BPA - Blood Transfusion Services
Department of the Air Force, FA8601 AFLCMC Pzio
Combined synopsis and solicitationNAICS 621991Wright-Patterson AFB, OHFA860127Q0015Closes in 2 daysNov 3
Description
As published on SAM.gov.
Solicitation Number:75F40124Q00412 This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE SOLICITATION WILL NOT BE ISSUED.
The solicitation number for this acquisition is 75F40124Q00412 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 621991. This will be awarded as Firm-Fixed Price as competed as Full and Open. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV.
The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary. The U.S. Food and Drug Administration (FDA) requires a Human Donor Blood for BioAssay Development Delivery. A. OBJECTIVES/PURPOSE For the development of bioassays using peripheral blood mononuclear cells (PBMC) and/or isolated immune cells, we require a reliable and steady source of blood products from human donors. See attached RFQ CB Synopsis Solicitation .
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Stemexpress, LLC
- UEI
- V6D4CLG1QU37
- CAGE
- 5VLJ3
- Vendor location
- Folsom, CA
- Contract
- 75F40124P00405, purchase order
- Obligated
- $47,440.00
- Actions
- 2 between September 6, 2024 and July 29, 2026
- Competition
- Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Human Donor Blood for Bioassay Development
- Match
- solicitation number 75F40124Q00461 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 3, 2024
Combined synopsis and solicitation
Due August 13, 2024 at 10:00 AM EDT. SAM.gov, notice 9a5ec4fcbd214b56a75e18b0c6481c8c
Points of contact
- PATRICIA NATIVIDADPATRICIA.NATIVIDAD@FDA.HHS.GOV3017968919